Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (statins) are the
most effective and best-tolerated drugs to treat elevated levels of low-density lipoprotein …

Sudden cardiac death, which is mainly associated with the presence of life-threatening
ventricular arrhythmias, is a common 'killer'among patients with coronary artery disease …

Sudden cardiac death is an important cause of cardiovascular mortality with the majority of
cases occurring in low-risk groups. HMG-CoA reductase inhibitors (statins) have recently …

Background Recent studies have demonstrated that statins may possess anti‐arrhythmic
properties in addition to their lipid‐lowering effects. Methods Studies which reported the …

Cardiac arrhythmias are a leading cause of morbidity and mortality in the Western world.
Ventricular arrhythmias are reportedly responsible for the majority of sudden cardiac deaths …

3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, statins, are potent
and widely used cholesterol-lowering drugs. Since the pathophysiology of atherosclerosis …

The underlying cause of heart disease is a process called atherosclerosis. Atherosclerosis
has been described simply as hardening of the arteries, but in truth, it involves a complex …

Aims The effect of statin treatment on ventricular arrhythmic complications is uncertain. We
sought to test whether statins reduce the risk of ventricular tachyarrhythmia, cardiac arrest …

Statins are, to date, the most powerful cholesterol lowering drugs. In brief, they inhibit 3-
hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase, which is a key enzyme in the …

The HMG-CoA reductase inhibitors (statins) are now considered the most potent lipid-
lowering drugs. Treatment with statins reduces both morbidity and mortality rates due to …